Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs Teladoc Health

Queen RX
Graded #214

Higher grade

vs+10.100000000000001
Teladoc Health
Graded #429

Lower grade

The verdict

Queen RX takes it — 66/100 to 55.9/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +31
76
45
Dose & formulationQueen RX +17
57
40
Clinical oversightTeladoc Health +8
69
77
Labs & monitoringTeladoc Health +8
53
61
FulfillmentQueen RX +11
75
64
Contract termsQueen RX +6
61
55
Queen RX · left barTeladoc Health · right bar

The numbers

MetricQueen RXTeladoc Health
WeighScore66/10055.9/100
GradeCC
Scorecard rank#214#429
Semaglutide$100/mo (quarterly plan, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
Teladoc Health

Graded #429 · C

Strengths

  • Dedicated GLP-1 Prescription and Support program for weight management
  • Backed by one of the largest virtual care companies in the US
  • Partners with 50%-plus of Fortune 500 and 100-plus health plans
  • Adds nutrition, coaching and connected device tracking
  • Strong clinical credibility and brand trust

Where it loses points

  • Distributed mainly via employers and health plans, limited direct cash-pay
  • No transparent published monthly price for GLP-1 care
  • Specific medications and eligibility vary by plan coverage
  • Member experience can depend on the employer's chosen configuration

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard